Related Experiment Video
Updated: Jul 13, 2026

Using Caco-2 Cells to Study Lipid Transport by the Intestine
Published on: August 20, 2015
The expression of the solute carriers NTCP and OCT-1 is regulated by cholesterol in HepG2 cells
1Centre for Molecular and Structural Biomedicine, Institute for Biotechnology and Bioengineering (IBB), University of Algarve, Faro, Portugal.
Abstract:
Drug disposition and response are greatly determined by the activities of drug-metabolizing enzymes and transporters. While the knowledge in terms of CYP enzymes and efflux ABC transporters (such as MDR1, P-glycoprotein) is quite extensive, influx transporters are increasingly being unveiled as key contributors to the process of drug disposition. There is little information on the regulation of these proteins in human cells, especially as regards the effect of endogenous compounds. In this study, we analysed the expression of CYP3A4 and three uptake transporters NTCP (SLC10A1), OATP-A/OATP1A2 (SLCO1A2) and OCT-1 (SLC22A1) in HepG2 cells following treatment with cholesterol. While CYP3A4 and OATP1A2 expression was unaffected, cholesterol treatment led to increased levels of NTCP and OCT-1 mRNAs. Alterations in the functional characteristics and/or expression levels of drug transporters in the liver may conceivably contribute to the variability in drug oral bioavailability often observed in the clinical settings.
Insights
Cholesterol increases the expression of key drug uptake transporters NTCP and OCT-1 in liver cells. This finding may help explain variations in how patients respond to medications.
Area of Science:
- Pharmacology
- Hepatology
- Molecular Biology
Background:
- Drug disposition and response are influenced by drug-metabolizing enzymes and transporters.
- While CYP enzymes and efflux transporters are well-studied, influx transporters' roles in drug disposition are increasingly recognized.
- Information on the regulation of these transporters by endogenous compounds in human cells is limited.
Purpose of the Study:
- To investigate the effect of cholesterol on the expression of CYP3A4, NTCP (SLC10A1), OATP1A2 (SLCO1A2), and OCT-1 (SLC22A1) in HepG2 cells.
- To explore the potential impact of endogenous compounds on drug transporter regulation.
Main Methods:
- HepG2 cells were treated with cholesterol.
- Expression levels of CYP3A4, NTCP, OATP1A2, and OCT-1 were analyzed using mRNA analysis.
- Functional characteristics of transporters were assessed.
Main Results:
- Cholesterol treatment did not affect CYP3A4 and OATP1A2 expression.
- Cholesterol significantly increased the mRNA levels of NTCP and OCT-1.
- Functional alterations in drug transporters may occur.
Conclusions:
- Cholesterol influences the expression of specific drug uptake transporters (NTCP, OCT-1) in liver cells.
- These alterations in transporter expression may contribute to inter-individual variability in drug bioavailability and clinical response.
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Transcellular Transport of Solutes
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Regulation of Nuclear Protein Sorting
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...

